SCHEMBL4466496

SCHEMBL4466496

CC(F)C(F)(F)S(=O)(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11271020 0.77
SCHEMBL4200386 0.74
SCHEMBL20485691 0.74
SCHEMBL11867358 0.72
SCHEMBL20502522 0.72
SCHEMBL3132836 0.72 ALDH1A1 (0.36)
SCHEMBL3625745 0.72
SCHEMBL18129680 0.72 CA1 (0.45)
SCHEMBL4602236 0.72
SCHEMBL28662726 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111653688-B Composite material, preparation method thereof and quantum dot light-emitting diode TCL科技集团股份有限公司 2021-09-14 CN claimed
CN-111653688-A Composite material, preparation method thereof and quantum dot light-emitting diode TCL集团股份有限公司 2020-09-11 CN claimed
US-20210061813-A1 NOVEL TRICYCLIC COMPOUNDS ABBVIE INC. (US) 2021-03-04 US disclosed
US-20160222020-A1 NOVEL TRICYCLIC COMPOUNDS ABBVIE INC. (US) 2016-08-04 US disclosed
WO-2015065336-A1 RESPIRATORY SYNCYTIAL VIRUS INHIBITORS MEDIVIR AB (SE) 2015-05-07 WO disclosed
US-7576095-B2 Therapeutic agents ASTRAZENECA AB (SE) 2009-08-18 US disclosed
US-20080009513-A1 Therapeutic agents ASTRAZENECA AB (SE) 2008-01-10 US disclosed